Neurological signs and the positive-negative dimension in schizophrenia

Biological Psychiatry

Volumn 28, Issue 3, 1990, Pages 181-192

  Merriam, Arnold E ^a   Kay, Stanley R ^a   Opler, Lewis A ^a,b   Kushner, Stuart F ^c   van Praag, Herman M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c Psychiatric Diagnostic Laboratories of America   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; APRAXIA; ARTICLE; CLINICAL ARTICLE; DEFECT SYNDROME; EXTRAPYRAMIDAL SYNDROME; HUMAN; INTELLECT; NEUROPSYCHOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; CHLORPROMAZINE; CHRONIC DISEASE; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; DYSKINESIA, DRUG-INDUCED; FRONTAL LOBE; HUMAN; MALE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PARIETAL LOBE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0025285904     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(90)90573-K     Document Type: Article

References (52)

1. The neuroleptic hypothesis Study of the covariation of the extrapyramidal and therapeutic drug effects
2. The Quick Test (QT): Provisional manual
3. Structural abnormalities in the frontal system in schizophrenia A magnetic resonance imaging study
4. Negative v positive schizophrenia: Definition and validation
5. Motor abilities after frontal leukotomy
6. Physiologic dysfunction or dorsolateral prefrontal cortex in schizophrenia IV Further evidence for regional and behavioral specificity
7. Physiologic dysfunction or dorsolateral prefrontal cortex in schizophrenia: II. Role of neuroleptic treatment, attention, and mental effort
8. Motor perseverations in schizophrenia
9. Auditory-visual integration in brain-damaged and normal children
10. Recall and recognition vocabulary: Implications for intellectual deterioration
11. The recognition and management of drug-induced movement disorders (reversible type)
12. Treatment of negative symptoms
13. Molecular pathology of schizophrenia. More than one disease process?
14. The two-syndrome concept: Origins and current status
15. Memory-for-Designs Test Revised general manual
16. Significance and meaning of neurological signs in schizophrenia
17. Neurologic organization in psychiatrically disturbed adolescent girls
18. Three cases of frontal meningiomas presenting psychiatrically
19. A negative symptom rating scale
20. The dementia of dementia praecox
21. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
22. The positive-negative dimension in schizophrenia: Its validity and significance
23. Reliability and validity of the Positive and Negative Syndrome Scale for schizophrenics
24. Schizophrenia with good and poor outcome III: Neurological “soft” signs, cognitive impairment, and their clinical significance
25. Disturbed voluntary motor activity in schizophrenic disorders
26. The subcortex, frontal lobes, and psychosis
27. Identical twins discordant for schizophrenia: Neurologic findings
28. Neurological differences between paranoid and nonparanoid schizophrenia: Part III. Neurological soft signs
29. Positive and negative syndromes in chronic schizophrenic inpatients
30. The disabilities of chronic schizophrenia — Their nature and the factors contributing to their development
31. Cognitive abnormalities
32. Lateral ventricular enlargement associated with persistent unemployment and negative symptoms in both schizophrenia and bipolar disorder
33. Neurological soft signs in schizophrenia and character disorders: Organicity in schizophrenia with premorbid asociality and emotionally unstable character disorders
34. Neurological syndrome following bilateral damage to the head of the caudate nuclei
35. Neuropsychological impairments in functional psychiatric diseases
36. Cerebral structural pathology in schizophrenia: Evidence for a selective prefrontal cortical defect
37. Frontal lobe syndrome in a patient with bilateral globus pallidus lesions
38. Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia
39. Schizophrenia and the frontal lobe
40. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. III: A new cohort and evidence for a monoaminergic mechanism
41. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence
42. Neurologic abnormalities in schizophrenic patients and their families. I. Comparison of schizophrenic, bipolar, and substance abuse patients and normal controls
43. Negative symptoms: Are they indigenous to schizophrenia?